Literature DB >> 16462346

Functional upgrading of partially recovered facial palsy by cross-face nerve grafting with distal end-to-side neurorrhaphy.

Manfred Frey1, Pietro Giovanoli, Maria Michaelidou.   

Abstract

BACKGROUND: Cross-face nerve grafting combined with functional muscle transplantation has become the standard in reconstructing an emotionally controlled smile in complete irreversible facial palsy. A special problem exists in incomplete or partially recovered facial palsies, when the little existing function should be preserved but the existing function alone is clinically insufficient.
METHODS: In this situation, cross-face nerve grafting performed by means of end-to-end coaptation to a zygomatic branch of the healthy side and by end-to-side neurorrhaphy to a corresponding branch of the incompletely paralyzed side is proposed to upgrade smile function on the latter side and contribute to more static and dynamic overall symmetry. The interposition nerve graft is set in overlength to preserve the possibility of a later muscle transplantation in case of unsatisfying functional result through the additional neuronal input. The authors have used this concept in seven patients with irreversible partial facial palsy. Three cases have a sufficiently long follow-up to be presented here. Outcome was objectively quantified with three-dimensional video analysis of facial movements.
RESULTS: In all three cases, functional improvement and a positive effect on the static and dynamic symmetry of the face could be measured. None of the patients was disappointed by the smile function achieved or wanted to undergo additional muscle transplantation.
CONCLUSION: On the basis of these first clinical experiences, the authors recommend cross-face nerve grafting with overlength and a distal end-to-side neurorrhaphy in patients with irreversible incomplete facial palsy affecting the smile.

Entities:  

Mesh:

Year:  2006        PMID: 16462346     DOI: 10.1097/01.prs.0000197136.56749.c6

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  Skin reference point for the zygomatic branch of the facial nerve innervating the orbicularis oculi muscle (anatomical study).

Authors:  A Chatellier; D Labbé; E Salamé; H Bénateau
Journal:  Surg Radiol Anat       Date:  2012-09-29       Impact factor: 1.246

2.  Effect of Distal Masseter to Facial Nerve Transfer in Paralytic Patients with Preserved Facial Nerve Continuity on Improving Scaled Measurement of Improvement in Lip Excursion (SMILE): A Vectoral Analysis.

Authors:  Berke Özücer; Osman Halit Çam
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-12-01

Review 3.  Clinical applications of end-to-side neurorrhaphy: an update.

Authors:  Pierluigi Tos; Giulia Colzani; Davide Ciclamini; Paolo Titolo; Pierfrancesco Pugliese; Stefano Artiaco
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

4.  Plasticity of Unmyelinated Fibers in a Side-to-end Tubulization Model.

Authors:  Vânia Tognon-Miguel; Adriana H Nascimento-Elias; Maria C L Schiavoni; Amilton A Barreira
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-09

5.  Cross-Face Nerve Grafting with Infraorbital Nerve Pathway Protection: Anatomic and Histomorphometric Feasibility Study.

Authors:  Joseph Catapano; Daniel R B Demsey; Emily S Ho; Ronald M Zuker; Gregory H Borschel
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-23

6.  End-to-end and end-to-side neurorrhaphy between thick donor nerves and thin recipient nerves: an axon regeneration study in a rat model.

Authors:  Tohru Tateshita; Kazuki Ueda; Akiyoshi Kajikawa
Journal:  Neural Regen Res       Date:  2018-04       Impact factor: 5.135

7.  Axon numbers and landmarks of trigeminal donor nerves for corneal neurotization.

Authors:  Eva Györi; Chieh-Han John Tzou; Wolfgang J Weninger; Lukas Reissig; Ursula Schmidt-Erfurth; Christine Radtke; Roman Dunavoelgyi
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.